Werewolf Therapeutics, Inc. HOWL
Set alert
0.99 USD -0.11 -10.35%
At close · Oct 30
0.99 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
0.97 Day range 1.09
0.308 52-week range 1.40
- YTD
- +55.54%
- 1 year
- -29.56%
- Open
- 1.09
- Prev close
- 1.10
- Mkt cap
- 47.93M
- Vol
- 415.56K
- Avg vol
- 6.73M
- EPS
- -0.73
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.97
- High
- 1.09
- Forward P/E
- -0.86
- Beta
- 0.41
- Short ratio
- 2.09
- Inst. own
- 72.62%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 2.11
- 200-d avg
- 3.31
- 1y target
- 12.00
MAX chart
Events in this range
- Mar 7, 2024Earnings: -0.33; estimate -0.43; surprise 23.26%
- May 3, 2024Earnings: -0.39; estimate -0.35; surprise -11.43%
- May 3, 2024Earnings: —; estimate -0.35; surprise —%
- Jun 3, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Jun 4, 2024Rating: JMP Securities · Market Outperform → Market Outperform
- Jun 26, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Jun 26, 2024Rating: JMP Securities · Market Outperform → Market Outperform
- Jul 2, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Aug 8, 2024Earnings: -0.43; estimate -0.38; surprise -13.16%
- Aug 8, 2024Earnings: —; estimate -0.38; surprise —%
- Nov 7, 2024Earnings: -0.38; estimate -0.41; surprise 7.32%
- Nov 19, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (83)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 27, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 27, 2026 | 3 months ago |
| SMA: Bullish | Jul 20, 2026 | 3 months ago |
| MACD: Sell Signal | May 18, 2026 | 5 months ago |
| SMA: Bearish | Apr 27, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 9, 2026 | 7 months ago |
| SMA: Bullish | Mar 2, 2026 | 8 months ago |
| SMA: Bearish | Feb 23, 2026 | 8 months ago |
| SMA: Bullish | Feb 16, 2026 | 8 months ago |
| SMA: Bearish | Nov 3, 2025 | 12 months ago |
| MACD: Sell Signal | Nov 3, 2025 | 12 months ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Aug 11, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | Jul 7, 2025 | 1 year ago |
| SMA: Bearish | Jun 23, 2025 | 1 year ago |
| SMA: Bearish | Jun 9, 2025 | 1 year ago |
| SMA: Bullish | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 14, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 31, 2025 | 1 year ago |
| RSI: Oversold | Mar 31, 2025 | 1 year ago |
| SMA: Bearish | Feb 17, 2025 | 1 year ago |
| SMA: Bullish | Feb 10, 2025 | 1 year ago |
| SMA: Bearish | Nov 11, 2024 | 1 year ago |
| SMA: Bullish | Oct 21, 2024 | 2 years ago |
| MACD: Buy Signal | Sep 30, 2024 | 2 years ago |
| SMA: Bearish | Sep 16, 2024 | 2 years ago |
| SMA: Bullish | Sep 9, 2024 | 2 years ago |
| SMA: Bearish | Jun 3, 2024 | 2 years ago |
| SMA: Bullish | May 27, 2024 | 2 years ago |
| SMA: Bearish | May 13, 2024 | 2 years ago |
| SMA: Bearish | Apr 29, 2024 | 2 years ago |
| SMA: Bullish | Apr 22, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 8, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| RSI: Overbought | Feb 5, 2024 | 2 years ago |
| RSI: Overbought | Jan 1, 2024 | 2 years ago |
| SMA: Bullish | Dec 4, 2023 | 2 years ago |
| SMA: Bullish | Nov 20, 2023 | 2 years ago |
| SMA: Bearish | Nov 6, 2023 | 2 years ago |
| SMA: Bearish | Nov 6, 2023 | 2 years ago |
| SMA: Bullish | Oct 30, 2023 | 3 years ago |
| MACD: Buy Signal | Oct 30, 2023 | 3 years ago |
| SMA: Bullish | Oct 23, 2023 | 3 years ago |
| SMA: Bearish | Aug 28, 2023 | 3 years ago |
| SMA: Bearish | Aug 28, 2023 | 3 years ago |
| SMA: Bullish | Aug 21, 2023 | 3 years ago |
| SMA: Bullish | Aug 21, 2023 | 3 years ago |
| MACD: Sell Signal | Aug 7, 2023 | 3 years ago |
| SMA: Bearish | Jul 24, 2023 | 3 years ago |
| SMA: Bearish | Jul 24, 2023 | 3 years ago |
| SMA: Bullish | Jun 26, 2023 | 3 years ago |
| SMA: Bearish | Jun 19, 2023 | 3 years ago |
| SMA: Bullish | May 1, 2023 | 3 years ago |
| SMA: Bullish | May 1, 2023 | 3 years ago |
| SMA: Bearish | Feb 20, 2023 | 3 years ago |
| SMA: Bearish | Jan 30, 2023 | 3 years ago |
| SMA: Bullish | Jan 16, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 9, 2023 | 3 years ago |
| SMA: Bullish | Jan 2, 2023 | 3 years ago |
| MACD: Sell Signal | Oct 17, 2022 | 4 years ago |
| SMA: Bearish | Sep 12, 2022 | 4 years ago |
| SMA: Bullish | Aug 1, 2022 | 4 years ago |
| SMA: Bullish | Jul 4, 2022 | 4 years ago |
| SMA: Bearish | Jun 27, 2022 | 4 years ago |
| SMA: Bullish | Jun 20, 2022 | 4 years ago |
| SMA: Bearish | May 9, 2022 | 4 years ago |
| SMA: Bullish | May 2, 2022 | 4 years ago |
| MACD: Buy Signal | May 2, 2022 | 4 years ago |
| SMA: Bearish | Apr 11, 2022 | 4 years ago |
| SMA: Bullish | Apr 4, 2022 | 4 years ago |
| RSI: Oversold | Feb 28, 2022 | 4 years ago |
| RSI: Oversold | Jan 31, 2022 | 4 years ago |
| RSI: Oversold | Jan 10, 2022 | 4 years ago |
| SMA: Bearish | Nov 22, 2021 | 4 years ago |
| SMA: Bearish | Oct 18, 2021 | 5 years ago |
| SMA: Bullish | Oct 11, 2021 | 5 years ago |
| SMA: Bearish | Oct 4, 2021 | 5 years ago |
| SMA: Bullish | Aug 16, 2021 | 5 years ago |
| SMA: Bearish | Aug 2, 2021 | 5 years ago |
Key statistics
- Market cap
- 69.96M
- Enterprise value
- -15.19M
- Trailing P/E
- 0.00
- Forward P/E
- -0.86
- PEG ratio
- 0.00
- Price / sales
- 20.66
- Price / book
- 0.77
- EPS (TTM)
- -1.52
- Beta
- 0.41
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 3.39M
- Revenue growth
- 0.00%
- Free cash flow
- -27.67M
- Total cash
- 122.83M
- Total debt
- 36.78M
- Return on equity
- -61.56%
- Shares outstanding
- 44.56M
- Short % of float
- 4.67%
- 50-day average
- 2.11
- 200-day average
- 3.31
Analyst view
Consensus: none
Price target (mean) 12.00 +1116.9% upside
Now 0.9861
- Target (low)
- 8.00
- Target (mean)
- 12.00
- Target (high)
- 15.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy2
- Buy4
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 8, 2024
Expected Aug 8, 2024. Consensus EPS estimate -0.275.
Financials — quick view
HOWL Revenue — quarterly 21.00M
HOWL Net income — quarterly 3.67M
HOWL EPS — quarterly 0.08
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | -0.41 | -0.38 | +0.03 | +7.32% |
| Aug 8, 2024 | Jun 1, 2024 | -0.38 | -0.43 | -0.05 | -13.16% |
| Aug 8, 2024 | Jun 1, 2024 | -0.38 | — | — | — |
| May 3, 2024 | Mar 1, 2024 | -0.35 | -0.39 | -0.04 | -11.43% |
| May 3, 2024 | Mar 1, 2024 | -0.35 | — | — | — |
| Mar 7, 2024 | Dec 1, 2023 | -0.43 | -0.33 | +0.10 | +23.26% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 19, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Jul 2, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Jun 26, 2024 | JMP Securities | reit | Market Outperform | Market Outperform |
| Jun 26, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Jun 4, 2024 | JMP Securities | reit | Market Outperform | Market Outperform |
| Jun 3, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
About Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule that is in Phase I/Ib clinical trial for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule, which is in Phase I clinical trial for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- werewolftx.com
News
- Werewolf Therapeutics To Present Two Posters On WTX-124, WTX-330 Data At Upcoming SITC 2026 Annual Meeting
- Werewolf Therapeutics Selected for Oral Presentation and to Present Posters at the Society for Immunotherapy of Cancer's (SITC) 2026 Annual Meeting
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- 12 Health Care Stocks Moving In Friday's Intraday Session
- Gold Moves Higher; US Composite PMI Surges In August
- Dow Jumps 350 Points; BJ's Wholesale Club Posts Upbeat Earnings
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- Why Ross Stores Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
- Werewolf Therapeutics (HOWL) Stock Is Trending Overnight—Here's Why It Jumped 90% After Hours
- 12 Health Care Stocks Moving In Thursday's After-Market Session
Your note
Sign in to keep a note on HOWL — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 5, 2023 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| RA Capital Management, L.P. | 13.79% | 6,144,881 | 9.65M | Sep 29, 2024 |
| MPM Asset Management, LLC | 9.61% | 4,284,172 | 6.73M | Sep 29, 2024 |
| Pfm Health Sciences, Lp | 7.63% | 3,398,747 | 5.34M | Sep 29, 2024 |
| MPM BioImpact Capital LLC | 5.36% | 2,388,011 | 3.75M | Sep 29, 2024 |
| Bank of America Corporation | 4.83% | 2,153,717 | 3.38M | Sep 29, 2024 |
| Adage Capital Partners GP L.L.C. | 4.49% | 2,000,594 | 3.14M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.80% | 800,282 | 1.26M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.52% | 676,891 | 1.06M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.88% | 392,161 | 615.69K | Sep 29, 2024 |
| Fidelity Small Cap Index Fund | 0.70% | 310,654 | 487.73K | Aug 30, 2024 |
| iShares Russell 2000 Value ETF | 0.48% | 211,769 | 332.48K | Oct 30, 2024 |
| Fidelity Extended Market Index Fund | 0.38% | 171,305 | 268.95K | Oct 30, 2024 |